Grants for Nonprofits - Health

This grant provides funding to organizations in South Africa to implement targeted HIV prevention and care programs for high-risk populations, including youth, in various community settings such as schools and workplaces.

This funding opportunity supports the development of innovative tools and systems that help individuals collect and understand their health data to make informed decisions about their health.

The purpose of the NIA Career Transition Award (CTA) is to facilitate the transition of mentored researchers to tenure-track faculty conducting research that advances the mission of NIA. This three-year award provides protected time through salary and research support and is targeted at applicants who plan to start a tenure-track faculty position within a year of the award.

This funding opportunity provides financial support to nonprofit and government organizations that serve low-income residents in Hayward through various community improvement projects and services.

This funding opportunity supports nonprofit organizations and event organizers in Cattaraugus County to create tourism-driven events and attractions that encourage visitors to explore the area.

The Town of Trumbull is offering grants to community-based organizations and nonprofits that serve Trumbull residents through eligible programs, services, and capital investments. This funding originates from the federal government's ARPA program, specifically targeting the COVID-19 public health and economic response. The program aims to address the pandemic's impact on public health, as well as economic harms to households, small businesses, nonprofits, impacted industries, and the public sector within Trumbull. This initiative aligns with the town's commitment to supporting its community and mitigating the ongoing effects of the pandemic. The primary beneficiaries of this grant program are Trumbull residents, who will benefit from the services, programs, and capital investments provided by the selected community-based organizations and nonprofits. The overarching impact goal is to support the COVID-19 public health and economic recovery within the town. This includes addressing public health challenges exacerbated by the pandemic and alleviating economic hardships experienced by various sectors of the community. The program prioritizes projects, programs, and services exclusively within the Town of Trumbull that directly support the COVID-19 public health and economic response. Eligible activities include those that address the pandemic's impact on public health and mitigate economic harms to households, small businesses, nonprofits, impacted industries, and the public sector. There is a strong focus on organizations that demonstrate a palpable presence within the Town of Trumbull. Expected outcomes include improved public health conditions, reduced economic hardship for households and businesses, and enhanced capacity of local nonprofits and community-based organizations to serve Trumbull residents. Measurable results will likely involve reporting on the number of residents served, the specific public health and economic issues addressed, and the overall impact of the funded programs. Applicants are required to comply with federal reporting guidelines, including periodic project and expenditure reports, ensuring accountability and the ability to track progress. The Town of Trumbull's strategic priority in launching this grant program is to effectively deploy federal ARPA funds to create a tangible positive impact on its community in the wake of the COVID-19 pandemic. The theory of change is that by providing financial support to local organizations, the town can empower these entities to deliver targeted, effective interventions that directly address the pandemic's multifaceted challenges, thereby fostering a stronger, more resilient Trumbull. This program is not intended to replace other federal, state, or local ARPA assistance, reinforcing its role as a supplementary and focused effort.

The Catalyze Product Definition Funding Opportunity Announcement (FOA) offers early-stage financial support for the development and testing of medical device prototypes, identification of disease targets for diagnostics, and creation of research tools to treat heart, lung, blood, and sleep (HLBS) disorders, with the goal of advancing these projects to a stage where they can qualify for the NHLBI Catalyze Preclinical program or secure further development funding from other sources.

The Community Foundation of North Louisiana (CFNL) offers Primary Grants to existing organizations with annual revenues of $250,000 or more, focusing on critical program areas within Louisiana's Bossier and Caddo Parishes. While the exact mission of CFNL is not explicitly stated in the provided text, the grant program's alignment with "Civic Engagement," "Economic Development," "Education," "Environment," "Health & Science," "Human Services," and "Organizational Development" indicates a commitment to fostering a healthy, thriving community across various sectors. The target beneficiaries of this grant program are the residents of Caddo and/or Bossier Parishes, as all proposed programs must serve these geographic areas. The grants are designed to support initiatives that address specific community needs within the identified program areas. Although specific impact goals and expected outcomes are not detailed, the focus on these broad categories suggests an aim to improve overall quality of life, strengthen local economies, enhance educational opportunities, promote environmental stewardship, and provide essential human services. The emphasis on "Organizational Development" also suggests a goal to build capacity and sustainability within the non-profit sector. The grant prioritizes programs with a duration of 12 months or less, starting no earlier than June 1, 2025, and ending no later than December 31, 2026. This timeframe indicates a focus on projects with a defined scope and measurable impact within a reasonable period. The eligibility criteria, including IRS tax-exempt status, specific audit requirements based on gross revenue, and good standing with Form 990 filings, underscore the foundation's commitment to supporting financially responsible and compliant organizations capable of effectively managing grant funds. While a formal "theory of change" is not explicitly articulated, the grant's structure implies that by investing in organizations working within the specified program areas and adhering to rigorous eligibility standards, CFNL believes it can contribute to positive systemic changes and address key challenges in Caddo and Bossier Parishes. The foundation's strategic priorities appear to be centered on empowering local organizations that demonstrate both programmatic alignment and organizational integrity, thereby fostering a stronger, more resilient community through targeted and responsible philanthropy.

This program provides funding for predoctoral and postdoctoral researchers to advance the understanding and treatment of spinal cord injuries through innovative research.

This funding opportunity provides financial support to nonprofit organizations in Arizona to deliver direct counseling services to parents grieving the violent loss of their children.

The Indiana Criminal Justice Institute (ICJI) is offering the 2024-2025 Family Violence Prevention and Services Act (FVPSA) American Rescue Plan (ARP) Supplemental Funding Grant. This grant aims to prevent, prepare for, and respond to COVID-19, with a specific focus on increasing access to COVID-19 testing, vaccines, and mobile health units to mitigate the virus's spread and enhance support for domestic violence survivors and their dependents. The program aligns with the mission of supporting community-based projects that effectively aid victims of family violence, domestic violence, and dating violence. The primary beneficiaries of this grant are domestic violence shelters, domestic violence programs, culturally specific organizations, tribes, rural communities, racial and ethnic specific communities, and limited English proficient (LEP) individuals, as well as domestic violence survivors and their dependents. The impact goals are to eliminate barriers to COVID-19 testing and supplies, provide resources for onsite testing, ensure access to rapid testing, maintain and increase testing efforts, expand access to testing for underserved populations, and broaden COVID-19 mitigation activities. The grant prioritizes several key areas, including COVID-19 testing (viral and antibody tests, planning, training, reporting, and supply procurement), COVID-19 mitigation (reducing transmission, case investigation, contact tracing, screening, education, and referrals), and COVID-19 vaccine access (administration, outreach, education, appointment assistance, and transportation). Additionally, the grant supports mobile health units for testing, vaccine administration, and preventative health services, along with workforce expansions, capacity building, and personnel support to ensure the continuity of domestic violence services. Expected outcomes include increased access to COVID-19 testing and vaccines, reduced spread of the virus, and enhanced support systems for domestic violence survivors. Measurable results will likely involve the number of individuals tested, vaccinated, and reached through mobile health units, as well as improvements in survivor services. The ICJI's strategic priority is to give special emphasis to community-based projects carried out by nonprofit private organizations that operate shelters or provide counseling, advocacy, and self-help services to victims of family violence. The theory of change suggests that by providing these supplemental funds, ICJI can strengthen the public health response to COVID-19 while simultaneously supporting and sustaining the advocacy workforce dedicated to preventing and responding to the needs of domestic violence survivors during the ongoing public health emergency.

This funding opportunity provides financial support for diverse organizations to develop and test community-driven strategies that enhance recruitment and retention of young participants in health research related to the long-term impacts of the 9/11 attacks.

This grant provides funding for nurse-led teams to develop innovative solutions that improve workplace conditions and well-being in health systems worldwide.

This funding opportunity is designed to support non-profit organizations in Fayetteville that provide essential services to individuals and families experiencing homelessness or at risk of becoming homeless, focusing on emergency shelter, street outreach, and housing stability.

This funding opportunity supports short courses that train researchers in advanced mental health research skills, targeting graduate students, postdoctoral scholars, and early-career investigators across the nation.

The Regional Opportunity Initiatives (ROI) is offering a second round of Digital Towns Grant funding to implement strategies that improve digital equity and inclusion across the Indiana Uplands. The program aligns with ROI's mission to advance a more digitally inclusive region by integrating digital information and communication into all aspects of communities. This grant is designed to support projects and programs that ensure Uplands citizens can fully participate in a digital society, going beyond just broadband expansion to include access to affordable internet, reliable devices, and sufficient digital skills and literacy. The target beneficiaries of this grant program are Uplands communities and organizations within the 11-county Indiana Uplands region, including incorporated cities and towns, county commissions and councils, libraries, nonprofits, public education institutions, faith-based organizations, Main Street organizations, chambers of commerce, economic development organizations with an affiliated 501(c)3, and organizations/programs that help businesses/entrepreneurs. The impact goal is to increase the digital capabilities of the region, ensuring everyone has the resources and skills to prosper in the digital age. The program focuses on three main themes: Digital Citizens, Digital Public Services, and Digital Business. Digital Citizens aims to help households connect to the internet, access devices, and grow competence in using digital technologies for internet services, e-commerce, educational opportunities, digital public services, and healthcare. Digital Public Services supports collaborations between local government, nonprofits, and healthcare to provide access to online information, services, and telehealth. Digital Business partners with businesses and entrepreneurs to maximize opportunities in the digital economy. Expected outcomes include financially supported projects that align with the Indiana Uplands Digital Inclusion Plan, leading to a more digitally inclusive region. Measurable results will be seen in increased access to affordable internet, reliable devices, and improved digital skills and literacy among citizens, as well as enhanced e-commerce opportunities for local businesses and improved access to digital public and healthcare services. ROI's strategic priority is to advance regional digital capabilities through funding for professional services, training, digital products, equipment/hardware, and other services that promote digital inclusion and prosperity. Applicants can receive between $5,000 and $50,000, with regional scope projects eligible for up to $75,000.

This Funding Opportunity Announcement (FOA) invites applications specific to sample acquisition, genome wide association studies, whole genome sequencing, quality control checking, variant calling, data calling, data sharing, data harmonization, and analysis that will support the generation of data from multi-ethnic cohorts for the Alzheimer's Disease Sequencing Project Follow-Up Study 2.0: The Diverse Population Initiative.Funding Opportunity Description Background This Funding Opportunity Announcement (FOA) is issued in response to National Alzheimer's Project Act (NAPA) milestones for the genetics of Alzheimer's disease (AD) and AD-related dementias (ADRD) in order to support the ongoing Alzheimer's Disease Sequencing Project (ADSP). The overarching goals of the ADSP are to: 1) identify new genes involved in AD/ADRD; 2) identify gene alleles contributing to increased risk for, or protection against, the disease; 3) provide insight as to why individuals with known risk factor genes escape from developing AD/ADRD; 4) identify potential avenues for therapeutic approaches and prevention of the disease; and 5) fully reveal the genetic architecture of AD/ADRD in multiple race and ethnicity categories. The samples for the ADSP were selected from well-characterized, diverse study cohorts of individuals both with and without an AD diagnosis as well as with and without known risk-factor genes. This study of human genetic variation and its relationship to health and disease involves a large number of study participants and aims to capture not only common single nucleotide variations, but also rare copy number and other structural variants that are increasingly thought to play an important role in complex diseases. This FOA uses the Office of Management and Budget (OMB) official categories of race and ethnicity. For the purposes of this FOA, ethnic categories (i.e., Hispanic/Latino) and racial categories (i.e., American Indian/Alaska Native; Asian; and Black/African American) will be referred to as diverse populations . Cohorts of participants from individual ethnic or race categories will be referred to as diversity cohorts . Individuals in diversity cohorts will be referred to as diversity participants . The ADSP has identified a large number of variations in the genomes of individuals affected with AD. The study population for these analyses was predominantly White. Lack of diversity in the sample set limits the possible clinical utility of emerging tools and methodological approaches for identifying potential therapeutics for a large proportion of the population. This, in turn, underscores the urgency to ensure appropriate representation of diverse populations to prevent potential gaps in the translation of research efforts to these populations. To this end, the initial ADSP findings will be pursued in diverse populations in the next phase of the study, called the ADSP Follow-Up Study (FUS) 2.0: The Diverse Population Initiative and referred to here as ADSP FUS 2.0. The long-term goals of the ADSP FUS 2.0 are to: 1) move the field closer to enabling prediction of who will develop AD; 2) fully characterize AD subtypes by studying endophenotypes in diverse populations; 3) better understand the differences in the genetic underpinnings of AD pathogenesis among diverse populations; and 4) identify specific therapeutic targets based upon diverse population. Important instances of unique AD/ADRD genetic variation have already been identified in epidemiological cohorts with Hispanic/Latino and Black/African American participants. Variants for AD are rare and can only be identified with a larger number of study participants. Variants occur at different frequencies in different populations, and certain risk variants may be much easier to detect in some populations. US diversity groups are not represented in ADSP data in sufficient numbers to enable meaningful study, so the genetics of these populations remain largely unstudied. Hispanics/Latinos, Blacks/African Americans, and Asians are the largest and fastest-growing minority groups in the US, and AD/ADRD imposes a high economic and social burden upon the US population. US Asian population ADSP genetic data are completely absent. Numbers of Hispanic/Latino and Black/African American participants in the US remain insufficient to provide statistical significance for identification of rare or very rare variants. Variants in the Alzheimer’s genome are largely rare or very rare in the population. It is estimated that for 80% certainty for single variant testing for rare variants, ~16,100 cases and ~16,100 controls are needed for a variant with a minor allele frequency of 0.5% in the population; single variant testing for rare variants indicate that for 90% certainty, ~18,500 cases and ~18,500 controls are needed for each population for a variant with a minor allele frequency of 1% in the population. To ensure that there are sufficient numbers of study participants to achieve statistical power for analysis of rare or vary rare variants in the three largest diversity cohorts AD/ADRD genome given the available funding, the primary focus of the ADSP FUS 2.0 will be on Hispanic/Latino, Black/African American, and Asian populations. Consortia should take advantage of cohorts already recruited or in planning for recruitment to obtain sufficient numbers; sharing diversity data across consortia is essential to the success of this effort. Investigators with cohorts representing other racial/ethnic categories, such as American Indians/Alaskan Natives, are encouraged to apply for funding separately under other NIA-supported FOAs. Sequencing of participants from founder populations such as those from Africa and Asia is allowed under this FOA in order to understand population substructure and ancestry-informative markers. A small amount of sequencing of Whites to bring significance to the 90% certainty of significance level will be allowed for rare or very rare variants for the US population; however, it is expected that the vast majority of sequencing in the ADSP FUS 2.0 will be done in Hispanics/Latinos, Blacks/African Americans, and Asians. Accelerated identification of AD/ADRD genes, gene clusters, and endophenotypes driven by genetic and ethnic/racial characteristics will move the field toward selection of participants with similar endophenotypes to improve outcomes of clinical trials. The community is now able to layer different types of data to identify these endophenotypes. Analytic approaches are being developed for analysis of structural and rare variants, endophenotypes, and cross-phenotype genetic analyses to modify and/or apply analytic methods to data that are increasingly complex. In order to identify optimal drug targets, the full landscape of genetic variants must be identified and characterized. Much work remains to develop analytic methods and resources to understand the functional significance of variants, particularly noncoding variants, in diverse populations. Under this funding opportunity announcement, studies that perform analysis of sequence data may include analysis of the functional genomic studies of regions of interest. Diversity datasets will need to be integrated and harmonized to fully annotate the AD genome. This may mean assembling annotation data such as that provided by ENCODE and similar approaches to help understand whether clusters of genes in the same network or with common function may be a component of the disease etiology that varies by ethnic and racial category. Applicants are encouraged to devise analysis plans to include data from genome wide association studies (GWAS) for AD; imputation analysis; ADSP whole exome and exome chip data, and whole genome AD sequencing efforts; related genetic data such as in deep (long read) sequencing analyses generated on AD subjects; and functional genomics data. Research Objectives NIA intends to support studies most likely to meet a major goal of this FOA: to identify and confirm a full set of rare variants contributing to AD/ADRD endophenotypes in diversity cohorts to enhance the probability of identifying potential therapeutic approaches for risk and prevention. Both sequencing and data analysis will be supported under this FOA. Applicants to this FOA for the ADSP FUS 2.0 should propose to: 1) sequence particular diverse study cohorts; 2) analyze either the entire dataset (cases and controls) or components of the dataset; or 3) both sequence and analyze these data. Justification for the choice of the approach must be provided. Applicants proposing to analyze only a component of the total cohort (i.e., selected cohorts or diverse subpopulations) should propose power calculations that support the likelihood of gene discovery. Applicants should design plans that clearly define which ADSP FUS 2.0 datasets, diverse subpopulations, and/or endophenotypes will be analyzed. Along with analysis of data funded under the present FOA, analysis plans for the ADSP FUS 2.0 should include data from diversity cohorts in the ADSP FUS funded under PAR-17-214, PAR-18-890, and PAR-19-234 where possible. The design and use of large-scale storage capacity with appropriate security and backup measures to support analytical capabilities should be considered. Successful applications are anticipated to involve research conducted by multidisciplinary teams of investigators and should describe a comprehensive plan to develop leading-edge, innovative approaches for the analysis of whole genome sequence (WGS) and related genetic data. Analysis should encompass the criteria set out by the ADSP FUS funded under PAR-17-214, "Analysis of Data from NIA's Alzheimer's Disease Sequencing Project Follow-Up Study (U01)." In particular, these criteria include ethnic/racial diversity; autopsy-confirmed cases/controls, especially for non-European ancestry; availability of longitudinal data; no age limit for cases; cases unrelated to each other; and availability of comparable controls. It is expected that the scientific environment in which the work will be done will contribute to the probability of success of the project and of the ADSP as a whole. Institutional support, equipment and other physical resources available to the investigators should be adequate for the project proposed, leveraging existing NIA-funded resources. Both the project itself and the ADSP should benefit from unique features of the scientific environment, subject populations, or collaborative arrangements. For applicants performing data analysis, it is expected that they will have the capacity to analyze whole-genome sequence data from sufficient numbers of affected and unaffected individuals to achieve statistical significance for rare or very rare variants in diverse groups. The successful milestone-driven ADSP FUS 2.0 application would consist of a group of researchers with expertise in the genetics of complex neurological diseases, including AD, and the field of whole genome sequencing, as well as statisticians and other experts who will participate in study design and analysis. Successful applicant(s) may be expected to collaborate not only within their own study, but also with other PD(s)/PI(s) funded under this and related FOAs. Engagement of existing NIA-supported infrastructure is considered essential to the success of the project, so applicants should plan to financially support the National Central Cell Repository for Alzheimer’s Disease (NCRAD); The American Genome Center (TAGC) at the Uniformed Services University for the Health Sciences (USUHS) or another NIA-approved, large-scale sequencing center; the Genome Center for Alzheimer's Disease (GCAD); and the NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) for their efforts in the ADSP. Applicants should develop key quantitative milestones with a timeline for accomplishment. Quality control (QC) and data harmonization will be performed by GCAD. The order and process for data transfer, quality control checking, and data harmonization will be agreed upon by the ADSP as a whole and will follow closely the existing paradigm. Under the present FOA, the ADSP will improve the likelihood of analyzing sequence data on enough different examples of events that change the genetic architecture of AD such that these data, when analyzed with existing ADSP datasets, will enhance the ability to better understand the genetic underpinnings of AD and to obtain a better understanding of rare risk and protective variants. The availability of high-quality, extensive phenotypic information on study participants is a critical consideration. Study design should include analysis of data from study participants with quantitative trait measures to more clearly define endophenotypes. Similarly, participants whose data will be used as controls should be well characterized. Applications considered for funding must effectively leverage NIA and NIH investments in infrastructure to support studies related to the genetics of Alzheimer’s disease. The investigators funded under this FOA may utilize information from existing NIA- and NIH-funded research resources or other federal websites such as: The NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) The Genome Center for Alzheimer's Disease (GCAD) The National Central Cell Repository for Alzheimer’s Disease (NCRAD) The National Alzheimer's Coordinating Center (NACC) The Alzheimer's Disease Genetics Consortium (ADGC) The Alzheimer's Disease Research Centers (ADRCs) Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) The Collaborative for Alzheimer’s Disease Research (CADRE) The Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimer's Disease Related Dementias (ADRD) The National Alzheimer’s Project Act (NAPA) Other websites designed to store and distribute data related to AD

This grant provides funding to nonprofit organizations and local entities in rural Missouri to improve mental health services and programs for youth aged 0-21.

Grant Opportunity: Branch County and Colon Grants Funding Organization: [Name of Funding Organization] Contact Information: [Contact details of the funding organization] Program Intent: The Branch County and Colon Grants aim to provide financial support to projects and programs that benefit the communities of Branch County and Colon. These grants are designed to assist nonprofit organizations in implementing initiatives that contribute to the overall well-being and development of these areas. Award Details: The grant cycle for this opportunity is conducted once per year, and applications are accepted through a competitive process. The specific amount of funding available for each grant is not mentioned in the provided information. However, successful applicants can expect to receive financial assistance towards their proposed projects or programs. Eligibility: Nonprofit organizations are eligible to apply for the Branch County and Colon Grants. There is no mention of any specific restrictions or requirements regarding the size or type of nonprofit organization that can apply. However, it is recommended that potential applicants thoroughly review the eligibility criteria outlined by the funding organization before submitting their applications. Other Relevant Information: It is important to note that only one grant cycle per year is available for this opportunity, so organizations should plan accordingly when considering their application timeline. Additionally, since this information has been scraped from a grant opportunity's website, it is advisable for potential applicants to visit the official website or contact the funding organization directly for more detailed information on application deadlines, guidelines, and any additional requirements or restrictions that may apply.

The Sussex County Council in Delaware is offering Human Service Grants ranging from $1,000 to $10,000 to established non-profit agencies in Sussex County, aiming to enhance health and human services and support programs or capital purchases, with the application deadline set for September 30, 2024.